ABSTRACT
Myocardial tissue tracking imaging techniques have been developed for a more accurate evaluation of myocardial deformation (i.e. strain), with the potential to overcome the limitations of ejection fraction (EF) and to contribute, incremental to EF, to the diagnosis and prognosis in cardiac diseases. While most of the deformation imaging techniques are based on the similar principles of detecting and tracking specific patterns within an image, there are intra- and inter-imaging modality inconsistencies limiting the wide clinical applicability of strain. In this review, we aimed to describe the particularities of the echocardiographic and cardiac magnetic resonance deformation techniques, in order to understand the discrepancies in strain measurement, focusing on the potential sources of variation: related to the software used to analyse the data, to the different physics of image acquisition and the different principles of 2D vs. 3D approaches. As strain measurements are not interchangeable, it is highly desirable to work with validated strain assessment tools, in order to derive information from evidence-based data. There is, however, a lack of solid validation of the current tissue tracking techniques, as only a few of the commercial deformation imaging softwares have been properly investigated. We have, therefore, addressed in this review the neglected issue of suboptimal validation of tissue tracking techniques, in order to advocate for this matter.
Subject(s)
Echocardiography, Three-Dimensional/methods , Heart Diseases/diagnostic imaging , Image Interpretation, Computer-Assisted , Magnetic Resonance Imaging, Cine/methods , Stroke Volume/physiology , Cardiac Imaging Techniques , Female , Heart Diseases/physiopathology , Humans , Male , Myocardial Contraction/physiology , Reproducibility of Results , SoftwareSubject(s)
Antitubercular Agents/therapeutic use , Multimodal Imaging/methods , Pericardial Effusion/diagnostic imaging , Tuberculosis, Cardiovascular/diagnostic imaging , Tuberculosis, Cardiovascular/therapy , Adult , Biopsy, Needle , Diagnosis, Differential , Dyspnea/diagnosis , Dyspnea/etiology , Echocardiography, Transesophageal/methods , Female , Follow-Up Studies , Granuloma, Plasma Cell/diagnosis , Granuloma, Plasma Cell/diagnostic imaging , Humans , Immunohistochemistry , Magnetic Resonance Imaging, Cine/methods , Mycobacterium tuberculosis/isolation & purification , Pericardial Effusion/diagnosis , Pericardial Effusion/microbiology , Thoracotomy/methods , Treatment Outcome , Tuberculosis, Cardiovascular/diagnosisABSTRACT
AIM: To evaluate if three-dimensional echocardiography (3-DE) is as accurate and reproducible as cine magnetic resonance imaging (cMR) in estimating left ventricular (LV) parameters in patients with and without wall motion abnormalities (WMA). METHODS: 83 patients (33 with WMA) underwent 3-DE and cMR. 3-DE datasets were analysed using a semi-automatic contour detection algorithm. The accuracy of 3-DE was tested against cMR in the two groups of patients. All measurements were made twice by two different observers. RESULTS: LV mass by 3-DE was similar to that obtained by cMR (149 (SD 42) g vs 148 (45) g, p = 0.67), with small bias (1 (28) g) and excellent interobserver agreement (-2 (31) g vs 4 (26) g). The two measurements were also highly correlated (r = 0.94), irrespective of WMA. End-diastolic and end-systolic LV volumes and ejection fraction by 3-DE and cMR were highly correlated (r = 0.97, 0.98, 0.94, respectively). Yet, 3-DE underestimated cMR end-diastolic volumes (167 (68) ml vs 187 (70) ml, p<0.001) and end-systolic volumes (88 (56) ml vs 101 (65) ml, p<0.001), but yielded similar ejection fractions (50% (14%) vs 50% (16%), p = 0.23). CONCLUSION: 3-DE permits accurate determination of LV mass and volumes irrespective of the presence or absence of WMA. LV parameters obtained by 3-DE are also as reproducible as those obtained by cMR. This suggests that 3-DE can be used to follow up patients with LV hypertrophy and/or remodelling.
